Novozymes A/s-unspons (NVZMY): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Who owns Novozymes A/s-unspons?
Novozymes A/s-unspons trades in the U.S. through ADRs, certificates that represent shares of a non-U.S. company. Form 13F counts ADRs while the company reports ordinary shares, so we do not compute percentages. As of Jun 30, 2026, the largest ADR holders reported on Form 13F were Rhumbline Advisers (12,425 ADRs), S&co (4,500 ADRs) and Alta Capital Management (3,793 ADRs).
Which institutions hold the most Novozymes A/s-unspons shares?
Per Form 13F filings as of Jun 30, 2026, in ADRs:
- 1. Rhumbline Advisers: 12,425 ADRs
- 2. S&co: 4,500 ADRs
- 3. Alta Capital Management: 3,793 ADRs
- 4. GAMMA Investing: 2,061 ADRs
- 5. Salomon & Ludwin: 246 ADRs
- 6. Sterling Capital Management: 150 ADRs
- 7. PNC Financial Services Group: 30 ADRs
- 8. IMA Advisory Services: 21 ADRs
- 9. First Command Advisory Services: 17 ADRs
We hold 13D and 13G filings made since December 2024: a holder above 5% that has not filed since then does not appear here.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders of NVZMY (all 13F filers)
- Rhumbline Advisers12 KIndex manager+2,352
- S&co4,500Type not verified0
- Alta Capital Management3,793Wealth adviser−66
- GAMMA Investing2,061Type not verified+548
- Salomon & Ludwin246Type not verified+187
- Sterling Capital Management150Type not verified0
- PNC Financial Services Group30Bank or trading desk+9
- IMA Advisory Services21Type not verified+8
- First Command Advisory Services17Type not verified+17
- Shares
- 12 K
- Change
- +2,352
See more
- Type
- Index manager
- Value
- $786K
- Shares
- 4,500
- Change
- 0
See more
- Type
- Type not verified
- Value
- $284K
- Shares
- 3,793
- Change
- −66
See more
- Type
- Wealth adviser
- Value
- $240K
- Shares
- 2,061
- Change
- +548
See more
- Type
- Type not verified
- Value
- $130K
- Shares
- 246
- Change
- +187
See more
- Type
- Type not verified
- Value
- $15.5K
- Shares
- 150
- Change
- 0
See more
- Type
- Type not verified
- Value
- $9.5K
- Shares
- 30
- Change
- +9
See more
- Type
- Bank or trading desk
- Value
- $1.9K
- Shares
- 21
- Change
- +8
See more
- Type
- Type not verified
- Value
- $1.3K
- Shares
- 17
- Change
- +17
See more
- Type
- Type not verified
- Value
- $1.1K
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗